Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Am J Gastroenterol. 2008 Jul 12;103(8):2106–2110. doi: 10.1111/j.1572-0241.2008.01994.x

Table 1.

Biomarkers That Have Been Proposed for Gastrointestinal Tumors

Colon Biomarkers Esophagus Biomarkers Pancreas Biomarkers Stomach Biomarkers
FAP Ki-67, P53, P16, COX-2, EGFR, CA19-9, CEA, K-ras, cagA, vacA, babA2, IL1
APC   EGF, TGF-α, β-catenin,   P53, P16, MIC-1,   gene, PGI, PGII, IgG
HNPCC   E-cadherin, c-erb-b2, cyclin   cyclin D2, TSLC1,   H. pylori
  hMSH2, hMLH1, hPMS1, hPMS2,   D1   SPARC
  hMSH3, hMSH6 LOH: 17p/P53, 9p/P16 Mitochondrial DNA
Sporadic Aneuploidy, tetraploidy,   mutation
  Tumor suppressor: P53, DCC, APC   Y-chromosome loss
  Oncogenes: Myc, ras, src, erbB2,
  MMR genes